The Current Ratio as of December 2025 (TTM) for Yunkang Group Limited (2325.HK) is 1.45

According to Yunkang Group Limited’s latest financial reports and current stock price. The company's current Current Ratio is 1.45. This represents a change of 2.33% compared to the average of 1.42 of the last 4 quarters.

Yunkang Group Limited (2325.HK) Historical Current Ratio (quarterly & annually)

How has 2325.HK Current Ratio performed in the past?

The mean historical Current Ratio of Yunkang Group Limited over the last ten years is 1.71. The current 1.45 Current Ratio has changed 8.42% with respect to the historical average. Over the past ten years (40 quarters), 2325.HK's Current Ratio was at its highest in in the June 2022 quarter at 2.41. The Current Ratio was at its lowest in in the September 2024 quarter at 1.39.

Yunkang Group Limited (2325.HK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Yunkang Group Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Yunkang Group Limited (2325.HK) Average Current Ratio

How has 2325.HK Current Ratio performed in the past?

The current Current Ratio of Yunkang Group Limited (2325.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Yunkang Group Limited (2325.HK) Current Ratio vs. Peers

How is 2325.HK’s Current Ratio compared to its peers?

Yunkang Group Limited’s Current Ratio is less than MOG Holdings Limited (3.32), greater than Charmacy Pharmaceutical Co., Ltd. (1.09), greater than Fusen Pharmaceutical Company Limited (0.57), less than Vincent Medical Holdings Limited (2.08), greater than Austar Lifesciences Limited (1.37), greater than China NT Pharma Group Company Limited (0.05), greater than China Biotech Services Holdings Limited (0.18), less than Suzhou Basecare Medical Corporation Limited (4.36), greater than ClouDr Group Limited (1.21), less than Zhongzhi Pharmaceutical Holdings Limited (1.54),

Build a custom stock screener for Yunkang Group Limited (2325.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Yunkang Group Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Yunkang Group Limited (2325.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Yunkang Group Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.